Aditx Therapeutics Inc. (ADTX) Issues Shareholder Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Aditxt Issues Shareholder Update
April 17, 2023 7:00 AM EDTRICHMOND, Va--(BUSINESS WIRE)-- Aditxt,® Inc, (NASDAQ: ADTX) (Aditxt or the Company), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation programs and strategic M&A initiatives.
PEARSANTA, INC. (IMMUNE MONITORING)
Aditxts Pearsanta Designated as... More



